Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
7,264
Value
$1.22M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,264$1.22M<0.1%−1,250−14.7%ReducedHolders
Q1 20268,514$1.12M<0.1%+120+1.4%AddedHolders
Q4 20258,394$1.19M<0.1%+643+8.3%AddedHolders
Q3 20257,751$1.09M<0.1%−332−4.1%ReducedHolders
Q2 20258,083$1.02M<0.1%−662−7.6%ReducedHolders
Q1 20258,745$967.2K<0.1%−787−8.3%ReducedHolders
Q4 20249,532$1.30M<0.1%−11,206−54.0%ReducedHolders
Q3 202420,738$2.39M<0.1%+9,780+89.2%AddedHolders
Q2 202410,958$1.51M<0.1%−871−7.4%ReducedHolders
Q1 202411,829$1.63M<0.1%+383+3.3%AddedHolders
Q4 202311,446$1.51M<0.1%−212−1.8%ReducedHolders
Q3 202311,658$1.31M<0.1%−355−3.0%ReducedHolders
Q2 202312,013$1.13M<0.1%−429−3.4%ReducedHolders
Q1 202312,442$1.26M<0.1%−2,889−18.8%ReducedHolders
Q4 202215,331$1.83M<0.1%+535+3.6%AddedHolders
Q3 202214,796$1.57M<0.1%+534+3.7%AddedHolders
Q2 202214,262$1.39M<0.1%−5,034−26.1%ReducedHolders
Q1 202219,296$1.81M<0.1%−5,006−20.6%ReducedHolders
Q4 202124,302$2.07M<0.1%−4,698−16.2%ReducedHolders
Q3 202129,000$2.78M<0.1%+1,452+5.3%AddedHolders
Q2 202127,548$2.68M<0.1%+5,559+25.3%AddedHolders
Q1 202121,989$2.14M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.